Mert Erkan
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Colorectal Cancer Surgical Treatments
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 61
- Pancreatic and Hepatic Oncology Research 50
- Cancer Cells and Metastasis 10
- Peptidase Inhibition and Analysis 6
-
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Jörg KleeffChristoph MichalskiHelmut FrießIréne EspositoNathalia A. GieseCarolin Reiser–ErkanSimone HausmannThomas Giese
- Journals
- Pancreatology (8 papers)Molecular Cancer (3 papers)Cancer Biology & Therapy (3 papers)PLoS ONE (3 papers)Annals of Surgery (3 papers)
- Partner nations
- GermanyTürkiyeUnited Kingdom
In The Last Decade
Mert Erkan
85 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 3.7k
- Cancer Research 1.1k
- Immunology 943
- Surgery 1.6k
- Molecular Biology 1.8k
Countries citing papers authored by Mert Erkan
This map shows the geographic impact of Mert Erkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mert Erkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mert Erkan more than expected).
Fields of papers citing papers by Mert Erkan
This network shows the impact of papers produced by Mert Erkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mert Erkan. The network helps show where Mert Erkan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mert Erkan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 97 | |
| 3 | 2020 | 30 | |
| 4 | 2019 | 53 | |
| 5 | 2016 | 57 | |
| 6 | 2016 | 104 | |
| 7 | 2016 | 5 | |
| 8 | 2015 | 182 | |
| 9 | Strategies to improve the outcome in locally advanced pancreatic cancer. | 2015 | 7 |
| 10 | 2015 | 105 | |
| 11 | 2015 | 13 | |
| 12 | 2015 | 70 | |
| 13 | 2014 | 121 | |
| 14 | 2014 | 42 | |
| 15 | 2013 | 60 | |
| 16 | 2008 | 43 | |
| 17 | 2008 | 118 | |
| 18 | 2007 | 113 | |
| 19 | 2006 | 123 | |
| 20 | 2005 | 189 |
About Mert Erkan
Mert Erkan is a scholar working on Oncology, Cancer Research, Surgery, Immunology and Developmental Neuroscience, having authored 85 papers that have together received 5.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (50 papers), Pancreatitis Pathology and Treatment (15 papers), Pancreatic function and diabetes (12 papers), Cancer Cells and Metastasis (10 papers), Phagocytosis and Immune Regulation (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Peptidase Inhibition and Analysis (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Oncology (3.7k citations), Cancer Research (1.1k citations), Immunology (943 citations), Surgery (1.6k citations) and Molecular Biology (1.8k citations). Mert Erkan has collaborated with scholars based in Germany, Türkiye and United Kingdom. Frequent co-authors include Jörg Kleeff, Christoph Michalski, Helmut Frieß, Iréne Esposito, Nathalia A. Giese, Carolin Reiser–Erkan, Simone Hausmann, Thomas Giese, Bo Kong and Helmut Friess. Their work appears in journals such as Pancreatology, Molecular Cancer, Cancer Biology & Therapy, PLoS ONE and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.